Tatiana Efimova

6PUBLICATIONS
9CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2026
p38β/MAPK11 Deficiency Exacerbates Cardiac Structural and Electrophysiological Remodeling and Contributes to Immune Dysregulation in the Aging Heart.

|Mar 24, 2026
RNAi-mediated p38δ silencing mitigates anthracycline cardiotoxicity in female mice.

Katy A Trampel, Katherine Y Gross, Daniel O'Reilly

|Feb 28, 2026
Age- and sex-specific modulation of human cardiac electrophysiology by doxorubicin.

Sharon A George, Amber V Mills, Erin O'Neill

|Jan 29, 2026
Selective RyR2 inhibition reduces arrhythmia susceptibility in human cardiac slices.

Micah K Madrid, Katy A Trampel, Batool Salman

|Aug 25, 2023
Anthracycline cardiotoxicity is exacerbated by global p38β genetic ablation in a sexually dimorphic manner but unaltered by cardiomyocyte-specific p38α loss.

Sharon A George, Alexi Kiss, Katy Anne Trampel

|Aug 02, 2021
Differential cardiotoxic electrocardiographic response to doxorubicin treatment in conscious versus anesthetized mice.

Anna Warhol, Sharon A George, Sofian N Obaid

Pageof 1

Frequent Collaborators

4 joint publications

Sharon A George

4 joint publications

Igor R Efimov

3 joint publications

Katy Anne Trampel

3 joint publications

Batool Salman